mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0003 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0003 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0004 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |